Winhe Pharma
Latest round
- Series C
Last raised
- Jul 2015
Total raised
- $13M
Investors
- 4
About Winhe Pharma
Established in 2008 and based in Yuxi, China, Winhe Pharma is a pharmaceutical company whose business integrates product research and development, drug production, herb cultivation and sales. The company has a GMP-certified production plant covering an area of more than 100 acres, 6500 acres of original ecological medicinal herbs plantation base, and the R&D center has been recognized as Yunnan Provincial Enterprise Technology Center. The company is mainly engaged in the research and development, production and sales of natural plant medicines with Panax notoginseng as the main raw material, as well as the plantation business of Panax notoginseng and other Chinese herbal medicines. The products are mainly cardiovascular and cerebrovascular drugs, supplemented by drugs for bruises and injuries, dispelling wind and removing dampness, and tonifying and nourishing blood, mainly including the Haematoxylin series, which consists of Haematoxylin Tablets, Haematoxylin Capsules and other 56 categories.
Who invested in Winhe Pharma
4 investors across 3 rounds
See all investors in Winhe Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Winhe Pharma
Who invested in Winhe Pharma?
Winhe Pharma has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Winhe Pharma raised?
Winhe Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Winhe Pharma last raise money?
Winhe Pharma's most recent round on record is a Series C, in Jul 2015.
What does Winhe Pharma do?
Established in 2008 and based in Yuxi, China, Winhe Pharma is a pharmaceutical company whose business integrates product research and development, drug production, herb cultivation and sales.
Where is Winhe Pharma headquartered?
Winhe Pharma is headquartered in Yuxi, China.
Which VCs invest in companies like Winhe Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Winhe Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Winhe Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.